Targeting Liver X Receptors for the Treatment of Non Alcoholic Fatty Liver Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyejin | - |
dc.contributor.author | Park, Chaewon | - |
dc.contributor.author | Kim, Tae Hyun | - |
dc.date.accessioned | 2023-06-26T07:40:05Z | - |
dc.date.available | 2023-06-26T07:40:05Z | - |
dc.date.issued | 2023-05-01 | - |
dc.identifier.issn | 2073-4409 | - |
dc.identifier.issn | 2073-4409 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/151508 | - |
dc.description.abstract | Non-alcoholic fatty liver disease (NAFLD) refers to a range of conditions in which excess lipids accumulate in the liver, possibly leading to serious hepatic manifestations such as steatohepatitis, fibrosis/cirrhosis and cancer. Despite its increasing prevalence and significant impact on liver disease-associated mortality worldwide, no medication has been approved for the treatment of NAFLD yet. Liver X receptors α/β (LXRα and LXRβ) are lipid-activated nuclear receptors that serve as master regulators of lipid homeostasis and play pivotal roles in controlling various metabolic processes, including lipid metabolism, inflammation and immune response. Of note, NAFLD progression is characterized by increased accumulation of triglycerides and cholesterol, hepatic de novo lipogenesis, mitochondrial dysfunction and augmented inflammation, all of which are highly attributed to dysregulated LXR signaling. Thus, targeting LXRs may provide promising strategies for the treatment of NAFLD. However, emerging evidence has revealed that modulating the activity of LXRs has various metabolic consequences, as the main functions of LXRs can distinctively vary in a cell type-dependent manner. Therefore, understanding how LXRs in the liver integrate various signaling pathways and regulate metabolic homeostasis from a cellular perspective using recent advances in research may provide new insights into therapeutic strategies for NAFLD and associated metabolic diseases. © 2023 by the authors. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI | - |
dc.title | Targeting Liver X Receptors for the Treatment of Non Alcoholic Fatty Liver Disease | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/cells12091292 | - |
dc.identifier.scopusid | 2-s2.0-85159234108 | - |
dc.identifier.wosid | 000986699600001 | - |
dc.identifier.bibliographicCitation | Cells, v.12, no.9 | - |
dc.citation.title | Cells | - |
dc.citation.volume | 12 | - |
dc.citation.number | 9 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | PROLIFERATOR-ACTIVATED RECEPTOR | - |
dc.subject.keywordPlus | REVERSE CHOLESTEROL TRANSPORT | - |
dc.subject.keywordPlus | DE-NOVO LIPOGENESIS | - |
dc.subject.keywordPlus | NUCLEAR RECEPTOR | - |
dc.subject.keywordPlus | LXR-ALPHA | - |
dc.subject.keywordPlus | LIPID-METABOLISM | - |
dc.subject.keywordPlus | DENSITY-LIPOPROTEIN | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | OXYSTEROL RECEPTORS | - |
dc.subject.keywordPlus | GLUCOSE-METABOLISM | - |
dc.subject.keywordAuthor | inflammation | - |
dc.subject.keywordAuthor | lipid metabolism | - |
dc.subject.keywordAuthor | liver X receptor | - |
dc.subject.keywordAuthor | non-alcoholic fatty liver | - |
dc.subject.keywordAuthor | pharmacological intervention | - |
dc.identifier.url | https://www.mdpi.com/2073-4409/12/9/1292 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.